Cargando…

N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop

Increasing evidence supports that N(6)-methyladenine (m(6)A) and long noncoding RNAs (lncRNAs) both act as master regulators involved in breast cancer (BC) tumorigenesis at epigenetic modification level. Here, our research tries to unveil the interaction of m(6)A and lncRNAs on BC progression and ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Saiyu, Zhang, Yuxing, Yang, Xiaodong, Li, Xue, Zheng, Yuexin, Liu, Yun, Zhang, Xiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275968/ https://www.ncbi.nlm.nih.gov/pubmed/36700472 http://dx.doi.org/10.1080/21655979.2022.2077893

Ejemplares similares

The biological function of m6A methyltransferase KIAA1429 and its role in human disease
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

m6A ‘writer’ KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis
por: Rong, Jian, et al.
Publicado: (2022)

KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN
por: Meng, Yu, et al.
Publicado: (2023)

LINC00667 regulates MPP(+)‐induced neuronal injury in Parkinson’s disease
por: Huo, Xinlong, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
por: Tang, Jun, et al.
Publicado: (2021)

N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner
por: Li, Ying, et al.
Publicado: (2022)

SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer
por: Zhang, Xu, et al.
Publicado: (2021)

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019)

KIAA1429/VIRMA promotes breast cancer progression by m(6)A‐dependent cytosolic HAS2 stabilization
por: Li, Na, et al.
Publicado: (2023)

m(6)A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
por: Xu, Ke, et al.
Publicado: (2023)

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
por: Lan, Tian, et al.
Publicado: (2019)

KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification
por: Kuang, Ye, et al.
Publicado: (2022)

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma
por: Luo, Jiaquan, et al.
Publicado: (2023)

m(6)A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m(6)A-dependent manner
por: Zhou, Yuan, et al.
Publicado: (2022)

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
por: Liu, Zhao-chen, et al.
Publicado: (2022)

KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells
por: Wang, Luying, et al.
Publicado: (2023)

N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression
por: Gan, Lijuan, et al.
Publicado: (2023)

CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma
por: Tan, Kezhe, et al.
Publicado: (2023)

m(6)A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA
por: Zhu, Zhongcheng, et al.
Publicado: (2022)

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

The m(6)A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
por: Yao, Fangyi, et al.
Publicado: (2023)

Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma
por: Zhang, Chang, et al.
Publicado: (2022)

DNA N(6)-methyladenine modification in hypertension
por: Guo, Ye, et al.
Publicado: (2020)

KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
por: Chen, Xiaomin, et al.
Publicado: (2023)

LINC00667 Sponges miR-4319 to Promote the Development of Nasopharyngeal Carcinoma by Increasing FOXQ1 Expression
por: Liao, Bing, et al.
Publicado: (2021)

KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner
por: Wang, Peng, et al.
Publicado: (2021)

No evidence for DNA N(6)-methyladenine in mammals
por: Douvlataniotis, Karolos, et al.
Publicado: (2020)

DNA N6-Methyladenine Modification in Eukaryotic Genome
por: Li, Hao, et al.
Publicado: (2022)

LINC00667/miR-449b-5p/YY1 axis promotes cell proliferation and migration in colorectal cancer
por: Yu, Juan, et al.
Publicado: (2020)

N(6)-methyladenine is incorporated into mammalian genome by DNA polymerase
por: Liu, Xiaoling, et al.
Publicado: (2020)

Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis
por: Li, Juncai, et al.
Publicado: (2023)

RNA N(6)-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness
por: Chen, Huarong, et al.
Publicado: (2022)

N6-methyladenine modification in noncoding RNAs and its function in cancer
por: Yang, Xinyu, et al.
Publicado: (2020)

N(6)-methyladenine: a potential epigenetic mark in eukaryotes
por: Huang, Shoujun, et al.
Publicado: (2015)

N6-methyladenine-modified DNA was decreased in Alzheimer’s disease patients
por: Lv, Shuang, et al.
Publicado: (2022)

N(6)-methyladenine in DNA antagonizes SATB1 in early development
por: Li, Zheng, et al.
Publicado: (2020)

LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge
por: Qin, Zhixiang, et al.
Publicado: (2021)

6mA-Pred: identifying DNA N6-methyladenine sites based on deep learning
por: Huang, Qianfei, et al.
Publicado: (2021)

N6-Methyladenine-Related Signature for Immune Microenvironment and Response to Immunotherapy in Hepatocellular Carcinoma
por: Ren, Shao-hua, et al.
Publicado: (2022)

RRM2 Regulated By LINC00667/miR-143-3p Signal Is Responsible For Non-Small Cell Lung Cancer Cell Progression
por: Yang, Yanbing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c3t2p4g6b6lt27reagg3nteb19